Stay updated on Carboplatin-Paclitaxel/Pembrolizumab in Squamous NSCLC Clinical Trial
Sign up to get notified when there's something new on the Carboplatin-Paclitaxel/Pembrolizumab in Squamous NSCLC Clinical Trial page.

Latest updates to the Carboplatin-Paclitaxel/Pembrolizumab in Squamous NSCLC Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedRevision updated to v3.6.3, replacing the previous v3.6.2. This reflects a new iteration of the study record rather than a substantive change to page content.SummaryDifference0.1%

- Check22 days agoChange DetectedRevision: v3.6.2 was added in the page footer, replacing the previous v3.6.0 label, indicating a software version update rather than a content change.SummaryDifference0.1%

- Check37 days agoChange DetectedRecruitment is no longer looking for participants. The record has been updated to revision v3.6.0, replacing the previous revision v3.5.5.SummaryDifference0.4%

- Check44 days agoChange DetectedA new revision entry v3.5.5 has been added to the record history, and the previous v3.5.4 entry has been removed from the list. This updates the version trail for the study record to reflect the latest revision.SummaryDifference0.1%

- Check65 days agoChange DetectedA new revision entry (v3.5.4) was added to the study's version history, and the previous revision (v3.5.3) was removed from the list.SummaryDifference0.1%

- Check86 days agoChange DetectedThe page’s displayed software revision/version number was updated from v3.5.2 to v3.5.3, reflecting a minor update to the ClinicalTrials.gov interface rather than a change to any trial record details.SummaryDifference0.1%

Stay in the know with updates to Carboplatin-Paclitaxel/Pembrolizumab in Squamous NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Carboplatin-Paclitaxel/Pembrolizumab in Squamous NSCLC Clinical Trial page.